Histamine H4 receptor expression in triple negative breast cancer: an exploratory study
Abstract: Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype. There are neither universally accepted prognostic markers, nor molecular targets related to TNBC. The histamine H4 receptor (H4R) has been characterized in TNBC experimental models, demonstrating its critical role in tumor development and progression. In this study, H4R expression was compared in breast cancer subtypes and correlated with clinical features using The Cancer Genome Atlas data (TCGA, Pan-Cancer Atlas). The H4R status was further evaluated by immunohistochemistry in 30 TNBC human samples in relation to clinicopathological parameters. Results indicate that H4R was downregulated in basal-like/TNBC compared with luminal A and normal breastlike tumors. The higher expression of H4R was associated with improved progression free and overall survival outcomes in basal-like/TNBC. H4R immunoreactivity was detected in about 70% of tumors, and its expression was positively correlated with the levels in the histologically normal peritumoral tissue. High H4R expression in peritumoral tissue correlated with reduced number of lymph node involvement and unifocal TNBC while it was associated with increased patient survival. In conclusion, the H4R might represent a potential prognostic biomarker in TNBC. Further studies in large cohorts are needed to better understand the significance of H4R in breast cancer biology.
Main Authors: | , , , , , , , , , |
---|---|
Format: | Artículo biblioteca |
Language: | eng |
Published: |
SAGE
2022
|
Subjects: | RECEPTOR DE HISTAMINA H4, INMUNOHISTOQUÍMICA, METÁSTASIS, MARCADOR PRONÓSTICO, CÁNCER DE MAMA TRIPLE NEGATIVO, |
Online Access: | https://repositorio.uca.edu.ar/handle/123456789/14023 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
oai:ucacris:123456789-14023 |
---|---|
record_format |
koha |
spelling |
oai:ucacris:123456789-140232022-11-09T15:11:47Z Histamine H4 receptor expression in triple negative breast cancer: an exploratory study Speisky, Daniela Táquez Delgado, Mónica Alejandra Iott, Alejandro Nicoud, Melisa Beatriz Ospital, Ignacio Vigovich, Félix Dezanzo, Pablo Ernst, Glenda Uriburu, Juan Luis Medina, Vanina Araceli RECEPTOR DE HISTAMINA H4 INMUNOHISTOQUÍMICA METÁSTASIS MARCADOR PRONÓSTICO CÁNCER DE MAMA TRIPLE NEGATIVO Abstract: Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype. There are neither universally accepted prognostic markers, nor molecular targets related to TNBC. The histamine H4 receptor (H4R) has been characterized in TNBC experimental models, demonstrating its critical role in tumor development and progression. In this study, H4R expression was compared in breast cancer subtypes and correlated with clinical features using The Cancer Genome Atlas data (TCGA, Pan-Cancer Atlas). The H4R status was further evaluated by immunohistochemistry in 30 TNBC human samples in relation to clinicopathological parameters. Results indicate that H4R was downregulated in basal-like/TNBC compared with luminal A and normal breastlike tumors. The higher expression of H4R was associated with improved progression free and overall survival outcomes in basal-like/TNBC. H4R immunoreactivity was detected in about 70% of tumors, and its expression was positively correlated with the levels in the histologically normal peritumoral tissue. High H4R expression in peritumoral tissue correlated with reduced number of lymph node involvement and unifocal TNBC while it was associated with increased patient survival. In conclusion, the H4R might represent a potential prognostic biomarker in TNBC. Further studies in large cohorts are needed to better understand the significance of H4R in breast cancer biology. 2022-05-26T12:24:52Z 2022-05-26T12:24:52Z 2022 Artículo Speisky, D. Histamine H4 receptor expression in triple negative breast cancer: an exploratory study [en línea]. Journal of Histochemistry and Cytochemistry. 2022, , 70 (4). doi: 10.1369/00221554221083670. Disponible en: https://repositorio.uca.edu.ar/handle/123456789/14023 0022-1554 https://repositorio.uca.edu.ar/handle/123456789/14023 1551-5044 (online) 10.1369/00221554221083670 eng Acceso abierto http://creativecommons.org/licenses/by-nc-sa/4.0/ application/pdf SAGE Journal of Histochemistry and Cytochemistry Vol. 70, No. 4, 2022 |
institution |
UCA |
collection |
DSpace |
country |
Argentina |
countrycode |
AR |
component |
Bibliográfico |
access |
En linea |
databasecode |
dig-uca |
tag |
biblioteca |
region |
America del Sur |
libraryname |
Sistema de bibliotecas de la UCA |
language |
eng |
topic |
RECEPTOR DE HISTAMINA H4 INMUNOHISTOQUÍMICA METÁSTASIS MARCADOR PRONÓSTICO CÁNCER DE MAMA TRIPLE NEGATIVO RECEPTOR DE HISTAMINA H4 INMUNOHISTOQUÍMICA METÁSTASIS MARCADOR PRONÓSTICO CÁNCER DE MAMA TRIPLE NEGATIVO |
spellingShingle |
RECEPTOR DE HISTAMINA H4 INMUNOHISTOQUÍMICA METÁSTASIS MARCADOR PRONÓSTICO CÁNCER DE MAMA TRIPLE NEGATIVO RECEPTOR DE HISTAMINA H4 INMUNOHISTOQUÍMICA METÁSTASIS MARCADOR PRONÓSTICO CÁNCER DE MAMA TRIPLE NEGATIVO Speisky, Daniela Táquez Delgado, Mónica Alejandra Iott, Alejandro Nicoud, Melisa Beatriz Ospital, Ignacio Vigovich, Félix Dezanzo, Pablo Ernst, Glenda Uriburu, Juan Luis Medina, Vanina Araceli Histamine H4 receptor expression in triple negative breast cancer: an exploratory study |
description |
Abstract: Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype.
There are neither universally accepted prognostic markers, nor molecular
targets related to TNBC. The histamine H4 receptor (H4R) has been
characterized in TNBC experimental models, demonstrating its critical role in
tumor development and progression. In this study, H4R expression was
compared in breast cancer subtypes and correlated with clinical features using
The Cancer Genome Atlas data (TCGA, Pan-Cancer Atlas). The H4R status
was further evaluated by immunohistochemistry in 30 TNBC human samples in
relation to clinicopathological parameters. Results indicate that H4R was
downregulated in basal-like/TNBC compared with luminal A and normal breastlike tumors. The higher expression of H4R was associated with improved
progression free and overall survival outcomes in basal-like/TNBC. H4R
immunoreactivity was detected in about 70% of tumors, and its expression was
positively correlated with the levels in the histologically normal peritumoral
tissue. High H4R expression in peritumoral tissue correlated with reduced
number of lymph node involvement and unifocal TNBC while it was associated
with increased patient survival. In conclusion, the H4R might represent a
potential prognostic biomarker in TNBC. Further studies in large cohorts are
needed to better understand the significance of H4R in breast cancer biology. |
format |
Artículo |
topic_facet |
RECEPTOR DE HISTAMINA H4 INMUNOHISTOQUÍMICA METÁSTASIS MARCADOR PRONÓSTICO CÁNCER DE MAMA TRIPLE NEGATIVO |
author |
Speisky, Daniela Táquez Delgado, Mónica Alejandra Iott, Alejandro Nicoud, Melisa Beatriz Ospital, Ignacio Vigovich, Félix Dezanzo, Pablo Ernst, Glenda Uriburu, Juan Luis Medina, Vanina Araceli |
author_facet |
Speisky, Daniela Táquez Delgado, Mónica Alejandra Iott, Alejandro Nicoud, Melisa Beatriz Ospital, Ignacio Vigovich, Félix Dezanzo, Pablo Ernst, Glenda Uriburu, Juan Luis Medina, Vanina Araceli |
author_sort |
Speisky, Daniela |
title |
Histamine H4 receptor expression in triple negative breast cancer: an exploratory study |
title_short |
Histamine H4 receptor expression in triple negative breast cancer: an exploratory study |
title_full |
Histamine H4 receptor expression in triple negative breast cancer: an exploratory study |
title_fullStr |
Histamine H4 receptor expression in triple negative breast cancer: an exploratory study |
title_full_unstemmed |
Histamine H4 receptor expression in triple negative breast cancer: an exploratory study |
title_sort |
histamine h4 receptor expression in triple negative breast cancer: an exploratory study |
publisher |
SAGE |
publishDate |
2022 |
url |
https://repositorio.uca.edu.ar/handle/123456789/14023 |
work_keys_str_mv |
AT speiskydaniela histamineh4receptorexpressionintriplenegativebreastcanceranexploratorystudy AT taquezdelgadomonicaalejandra histamineh4receptorexpressionintriplenegativebreastcanceranexploratorystudy AT iottalejandro histamineh4receptorexpressionintriplenegativebreastcanceranexploratorystudy AT nicoudmelisabeatriz histamineh4receptorexpressionintriplenegativebreastcanceranexploratorystudy AT ospitalignacio histamineh4receptorexpressionintriplenegativebreastcanceranexploratorystudy AT vigovichfelix histamineh4receptorexpressionintriplenegativebreastcanceranexploratorystudy AT dezanzopablo histamineh4receptorexpressionintriplenegativebreastcanceranexploratorystudy AT ernstglenda histamineh4receptorexpressionintriplenegativebreastcanceranexploratorystudy AT uriburujuanluis histamineh4receptorexpressionintriplenegativebreastcanceranexploratorystudy AT medinavaninaaraceli histamineh4receptorexpressionintriplenegativebreastcanceranexploratorystudy |
_version_ |
1756276525061111808 |